These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 29227473)

  • 1. Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.
    McCorvy JD; Butler KV; Kelly B; Rechsteiner K; Karpiak J; Betz RM; Kormos BL; Shoichet BK; Dror RO; Jin J; Roth BL
    Nat Chem Biol; 2018 Feb; 14(2):126-134. PubMed ID: 29227473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
    Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
    Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
    Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
    Xiao K; Sun J
    Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.
    Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N
    Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.
    Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA
    Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
    Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT
    Denzinger K; Nguyen TN; Noonan T; Wolber G; Bermudez M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
    Tan L; Yan W; McCorvy JD; Cheng J
    J Med Chem; 2018 Nov; 61(22):9841-9878. PubMed ID: 29939744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the GPCR biased signaling through G protein and arrestin complex structures.
    Zhou XE; Melcher K; Xu HE
    Curr Opin Struct Biol; 2017 Aug; 45():150-159. PubMed ID: 28558341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation.
    Ichikawa O; Fujimoto K; Yamada A; Okazaki S; Yamazaki K
    PLoS One; 2016; 11(5):e0155816. PubMed ID: 27187591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery.
    Zou Y; Ewalt J; Ng HL
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation.
    Piekielna-Ciesielska J; Artali R; Azzam AAH; Lambert DG; Kluczyk A; Gentilucci L; Janecka A
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
    Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
    J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy.
    Rahmeh R; Damian M; Cottet M; Orcel H; Mendre C; Durroux T; Sharma KS; Durand G; Pucci B; Trinquet E; Zwier JM; Deupi X; Bron P; Banères JL; Mouillac B; Granier S
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6733-8. PubMed ID: 22493271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.